293 related articles for article (PubMed ID: 29698399)
21. Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes.
Levin AM; Francis JH; McFadden M; Brodie S; Gobin YP; Abramson DH
PLoS One; 2019; 14(1):e0210647. PubMed ID: 30650131
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin +/- topotecan ophthalmic artery chemosurgery for intraocular retinoblastoma.
Francis JH; Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Jonna G; Abramson DH
PLoS One; 2013; 8(8):e72441. PubMed ID: 23991112
[TBL] [Abstract][Full Text] [Related]
23. Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma.
Francis JH; Barker CA; Wolden SL; McCormick B; Segal K; Cohen G; Gobin YP; Marr BP; Brodie SE; Dunkel IJ; Abramson DH
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):517-23. PubMed ID: 23953635
[TBL] [Abstract][Full Text] [Related]
24. Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment.
Shields CL; Kaliki S; Shah SU; Bianciotto CG; Jabbour P; Shields JA
Retina; 2012 Apr; 32(4):799-804. PubMed ID: 22105496
[TBL] [Abstract][Full Text] [Related]
25. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
26. Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.
Francis JH; Levin AM; Zabor EC; Gobin YP; Abramson DH
PLoS One; 2018; 13(5):e0197081. PubMed ID: 29791475
[TBL] [Abstract][Full Text] [Related]
27. Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma.
Abramson DH; Daniels AB; Marr BP; Francis JH; Brodie SE; Dunkel IJ; Gobin YP
PLoS One; 2016; 11(1):e0146582. PubMed ID: 26756643
[TBL] [Abstract][Full Text] [Related]
28. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
[TBL] [Abstract][Full Text] [Related]
29. Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma.
Reddy MA; Naeem Z; Duncan C; Robertson F; Herod J; Rennie A; Liasis A; Thompson DA; Sagoo M
Br J Ophthalmol; 2017 Dec; 101(12):1704-1708. PubMed ID: 28432112
[TBL] [Abstract][Full Text] [Related]
30. Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results.
Marr BP; Brodie SE; Dunkel IJ; Gobin YP; Abramson DH
Br J Ophthalmol; 2012 Oct; 96(10):1300-3. PubMed ID: 22863945
[TBL] [Abstract][Full Text] [Related]
31. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy.
Stacey AW; De Francesco S; Borri M; Hadjistilianou T
Ophthalmol Retina; 2021 Aug; 5(8):824-830. PubMed ID: 33221516
[TBL] [Abstract][Full Text] [Related]
32. Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report.
Marathe PH; Dunkel IJ; Francis JH; Antal Z; Gobin YP; Abramson DH; Friedman DN
Ophthalmic Genet; 2022 Dec; 43(6):806-808. PubMed ID: 36695494
[TBL] [Abstract][Full Text] [Related]
33. RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture.
Shields CL; Say EAT; Pefkianaki M; Regillo CD; Caywood EH; Jabbour PM; Shields JA
Retina; 2017 Aug; 37(8):1441-1450. PubMed ID: 27787452
[TBL] [Abstract][Full Text] [Related]
34. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Arch Ophthalmol; 2010 Mar; 128(3):370-2. PubMed ID: 20212212
[No Abstract] [Full Text] [Related]
35. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
[TBL] [Abstract][Full Text] [Related]
36. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
BMC Cancer; 2019 Jul; 19(1):693. PubMed ID: 31307410
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA
Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
[TBL] [Abstract][Full Text] [Related]
38. Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review.
Francis JH; Abramson DH; Gobin YP; Marr BP; Dunkel IJ; Riedel ER; Brodie SE
PLoS One; 2014; 9(1):e84247. PubMed ID: 24465398
[TBL] [Abstract][Full Text] [Related]
39. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization.
Klufas MA; Gobin YP; Marr B; Brodie SE; Dunkel IJ; Abramson DH
AJNR Am J Neuroradiol; 2012 Sep; 33(8):1608-14. PubMed ID: 22442047
[TBL] [Abstract][Full Text] [Related]
40. The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review.
Runnels J; Acosta G; Rose A; Haynes M; Nikolaidis D; Wong A; Fiani B
Clin Transl Oncol; 2021 Oct; 23(10):2066-2077. PubMed ID: 33826082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
